Back to Search
Start Over
Correction: ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer
- Source :
- BMC Cancer, Vol 24, Iss 1, Pp 1-2 (2024)
- Publication Year :
- 2024
- Publisher :
- BMC, 2024.
- Subjects :
- Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Subjects
Details
- Language :
- English
- ISSN :
- 14712407
- Volume :
- 24
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- BMC Cancer
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.89e1d4a9c33c48d7a1f7222dc8a7a449
- Document Type :
- article
- Full Text :
- https://doi.org/10.1186/s12885-024-12700-0